Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
11.55
-0.23 (-1.91%)
Mar 31, 2025, 9:47 AM EDT - Market open
Sotera Health Company Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Sotera Health Company stock have an average target of 16.3, with a low estimate of 13 and a high estimate of 20. The average target predicts an increase of 41.19% from the current stock price of 11.55.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 28, 2025.
Analyst Ratings
The average analyst rating for Sotera Health Company stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +38.59% | Feb 28, 2025 |
| Barclays | Barclays | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +47.25% | Feb 18, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +47.25% | Nov 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +73.24% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +47.25% | Aug 6, 2024 |
Financial Forecast
Revenue This Year
1.15B
from 1.10B
Increased by 4.14%
Revenue Next Year
1.22B
from 1.15B
Increased by 6.11%
EPS This Year
0.79
from 0.16
Increased by 405.38%
EPS Next Year
0.90
from 0.79
Increased by 13.78%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.2B | 1.3B | 1.3B |
| Avg | 1.1B | 1.2B | 1.3B |
| Low | 1.1B | 1.2B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 11.6% | 15.4% | 10.8% |
| Avg | 4.1% | 6.1% | 5.8% |
| Low | 0.2% | 1.6% | 1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2028 |
|---|---|---|---|
| High | 0.85 | 1.01 | 1.14 |
| Avg | 0.79 | 0.90 | 1.10 |
| Low | 0.70 | 0.78 | 1.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2028 |
|---|---|---|---|
| High | 442.4% | 27.7% | 26.9% |
| Avg | 405.4% | 13.8% | 22.1% |
| Low | 343.8% | -1.1% | 18.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.